Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Chemomab Therapeutics (CMMB): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$27
+1144.4%
Highest Price Target
$28
+1190.4%
Lowest Price Target
$25
+1052.2%
Short Interest
1.1%
Declining — Bullish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 27, 2025 | Oppenheimer | Jeff Jones— | +1052.2% | $10 → $25 | Maintained | Outperform |
| May 16, 2025 | Oppenheimer | Jeff Jones— | +360.9% | $11 → $10 | Maintained | Outperform |